RA-ILD: Tracking Function and CT - Poll - MDSpire

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

  • By

  • Kathryn Wighton

  • March 6, 2026

  • 4 min

Share

Original Source(s)

RA-ILD: Tracking Function and CT

  • by Kathryn Wighton

  • March 6, 2026

Related Content

Trial Exclusions May Skew RA Drug Comparisons

Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.

Ultrasound Models Estimate Whole-Body Muscle Mass

New equations incorporating cross-sectional area improve estimation accuracy.

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.